Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950129-97-000993
Filing Date
1997-03-11
Accepted
1997-03-11 00:00:00
Documents
5
Period of Report
1996-12-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 TEXAS BIOTECHNOLOGY CORPORATION - 12/31/96 10-K 220124
2 AMEND. #3 TO CONSULTING AGREEMENT EX-10.58 19652
3 AMEND. TO LICENSE & RESEARCH & DEVELOPMENT AGRMNT EX-10.59 3449
4 INDEPENDENT AUDITORS' CONSENT EX-23.1 1056
5 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000950129-97-000993.txt   248186
Mailing Address
Business Address DOCTORS CENTER 7000 FANNIN STE 1920 HOUSTON TX 77030 7137968822
TEXAS BIOTECHNOLOGY CORP /DE/ (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20117 | Film No.: 97554794
SIC: 2836 Biological Products, (No Diagnostic Substances)